1978
DOI: 10.1016/0006-2952(78)90180-6
|View full text |Cite
|
Sign up to set email alerts
|

Effects of pyrovalerone on peripheral noradrenergic mechanisms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
20
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(20 citation statements)
references
References 10 publications
0
20
0
Order By: Relevance
“…Pyrovalerone has inhibitory effects on both norepinephrine and dopamine reuptake [49][50][51] but in a single study, had little effect on serotonin reuptake. Examination of the chirality of the compound revealed the S-enantiomer to be the more biologically active than the R-enantiomer [52].…”
Section: Mechanism: Pyrovaleronementioning
confidence: 96%
“…Pyrovalerone has inhibitory effects on both norepinephrine and dopamine reuptake [49][50][51] but in a single study, had little effect on serotonin reuptake. Examination of the chirality of the compound revealed the S-enantiomer to be the more biologically active than the R-enantiomer [52].…”
Section: Mechanism: Pyrovaleronementioning
confidence: 96%
“…Pyrovalerone causes release [10,11] and reuptake inhibition [12] of dopamine and norepinephrine leading to psychostimulant effects similar to those of amphetamine but with lesser influence on motor function [13][14][15]. Pyrovalerone had been evaluated as a therapeutic drug in the 1960s and 1970s [16][17][18] but was scheduled as a controlled substance after reports of intravenous abuse [19].…”
Section: Introductionmentioning
confidence: 99%
“…1. Pyrovalerone is a psychostimulant which acts by releasing dopamine and norepinephrine from the respective nerve terminals [7,8]. It was first pharmacologically characterized in animal experiments by Stille et al [9] in the early 1960s.…”
Section: Introductionmentioning
confidence: 99%